PERITEC BIOSCIENCES

Basic Information

10000 cedar avenue
Cleveland, OH, 44195-

Company Profile

n/a

Additional Details

Field Value
DUNS: 156106952
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure

    Amount: $833,016.00

    DESCRIPTION (provided by applicant): An estimated 11.5 percent of adults (approx 23 million people) suffer from chronic kidney disease. Among people suffering from ESRD, the mortality is approximately ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Commercialization of Tissue Lined Stent Graft for Dialysis Access Failure

    Amount: $1,024,966.00

    DESCRIPTION (provided by applicant): An estimated 11.5 percent of adults (approx 23 million people) suffer from chronic kidney disease. Among people suffering from ESRD, the mortality is approximately ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Novel Biological Tissue Lined Vascular Stent Crimping and Delivery System

    Amount: $912,042.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in the United States and atherosclerosis is its major cause. Based on statistics for aging population alone, a ...

    SBIR Phase II 2009 Department of Health and Human Services
  4. Novel Biological Tissue Lined Vascular Stent Crimping and Delivery System

    Amount: $253,194.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in the United States and atherosclerosis is its major cause. Based on statistics for aging population alone, a ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government